Brooks Laboratories Limited

₹65.96As of Sun 8 Nov 2026, 12:00 UTC
NSE:BROOKSHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR (7.63%)
Div yield —
ROE 47.90%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.04
PE TTM 2.667
TSR TTM (40.54%)
Mkt cap ₹1.943B
ROIC 2.22%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹74
12.83%
262.55%
Hold 2|3|12|6|2
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.84
0.83
0.83
0.91
(5.61%)
(3.90%)
0.61%
4.48%
Revenue₹M
117.0
119.5
124.7
124.9
13.72%
9.91%
15.51%
12.56%
Peers (US$19.78M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.619
(0.351)
(0.349)
EBIT/Intx
1.128
1.448
1.283
Own earn%
61.32
39.70
34.10
Sh yield%
34.38
24.04
23.59
Owners
Insiders/Inst%
7.75
54.35
Short interest%
4.89
SBC / revenue%
2.81
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
0–1
$1 testx
—
Incr. ROIC%
27